In 2006, we recognized that we had a need to better understand clinical practices and true medical needs in order to assess new medical and diagnostic opportunities. Since then, we have built a global panel of more than 200 top medical experts (Key Opinion Leaders), most of whom are practising clinicians. We use this panel to discuss the relevance of new therapies and diagnostic methods and to select the most relevant indications for development.

Our current panel has extensive experience in oncology, CNS and inflammatory diseases. However, this unique network is continuously expanded to cover new therapeutic areas as new projects necessitate access to new expertises.